Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × Heavy Ion Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Carcinoma 1 Glioma 1

Interventions

Temozolomide 77 Bevacizumab 45 Radiotherapy 30 Irinotecan 19 Carboplatin 17 Magnetic Resonance Spectroscopy 16 Surgical Procedures, Operative 13 Carmustine 13 Radiation 9 Nivolumab 8 Erlotinib Hydrochloride 8 Thalidomide 7 Lomustine 7 Imatinib Mesylate 7 IL13-PE38 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 Radiotherapy, Intensity-Modulated 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Filgrastim 5 Blood Specimen Collection 5 temsirolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01166308 2018-05-17

CINDERELLA

University Hospital Heidelberg

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡